| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/06/2008 | WO2008026198A2 Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the cns |
| 03/06/2008 | WO2008025992A2 Methods of expanding non-effector cd8 t-cell populations |
| 03/06/2008 | WO2008025964A2 Antibodies to an epitope of agr2. assays and hybridomas |
| 03/06/2008 | WO2008025558A2 Affinity marker comprising a first and a second tag and its use |
| 03/06/2008 | WO2008007082A3 Cell growth medium |
| 03/06/2008 | WO2008006458A3 Epitope-tag for surface-expressed t-cell receptor proteins, uses thereof and method of selecting host cells expressing them |
| 03/06/2008 | WO2008000512A3 Method for identifying crmp modulators |
| 03/06/2008 | WO2007147975A3 Antigenic surface structure of sperm cells associated with the y chromosome |
| 03/06/2008 | WO2007140472A3 Cd127 expression inversely correlates with foxp3 and suppressive function of cd4+ tregs |
| 03/06/2008 | WO2007137301A8 Modulation of chrebp expression |
| 03/06/2008 | WO2007132279B1 Cholesterol loaded insect cell membranes as test systems for abc transporter proteins |
| 03/06/2008 | WO2007120811A3 Hemangio-colony forming cells |
| 03/06/2008 | WO2007089798A3 Methods of preparing and characterizing mesenchymal stem cell aggregates and uses thereof |
| 03/06/2008 | WO2007081465A3 Antibodies to interleukin-20 and method for inhibiting interleukin-20 induced cell proliferation |
| 03/06/2008 | WO2007002136A9 Differentiation of primate pluripotent stem cells to cardiomyocyte-lineage cells |
| 03/06/2008 | WO2006050379A3 Modulation of serotonin neurons involving the pet-1 transcriptional control region |
| 03/06/2008 | US20080060100 Polypeptide Having 5 Fatty Acid Desaturating Activity, Polynucleotide Coding for the Polypeptide, and Use Thereof |
| 03/06/2008 | US20080060099 Cell Cycle Nucleic Acids, Polypeptides and Uses Thereof |
| 03/06/2008 | US20080060098 Expression vector comprising nucleotide sequences coding transcription factors for generation of drought, freeze and salinity resistant plants |
| 03/06/2008 | US20080060097 Expression vector comprising nucleotide sequences coding transcription factors for generation of drought, freeze and salinity resistant plants |
| 03/06/2008 | US20080060092 Humanized glycoproteins isolated from plant bioreactors |
| 03/06/2008 | US20080060091 Method of Gene Introduction in In-Vivo Spermatogenic Cell |
| 03/06/2008 | US20080060087 Modified Cells and Methods of Using Same |
| 03/06/2008 | US20080058762 Induction And Maintenance Of Tolerance To Composite Tissue Allografts |
| 03/06/2008 | US20080058505 Modified parathyroid hormone/peptides for use in prevention and treatment of bone disorders |
| 03/06/2008 | US20080058433 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 03/06/2008 | US20080058376 Useful in treatment of diseases through the inhibition of sodium ion flux through voltage-dependent sodium channels; treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels; neuropathic pain |
| 03/06/2008 | US20080058330 Compounds and Combinations Thereof for Inhibiting Beta-Amyloid Production and Methods of Use Thereof |
| 03/06/2008 | US20080058298 Blocking hedgehog protein transduction signal passageway using alkaloid steroid |
| 03/06/2008 | US20080058297 Heterocyclic Compounds For Preventing And Treating Disorders Associated With Excessive Bone Loss |
| 03/06/2008 | US20080058278 Reduce oxygen toxicity in lung diseases, dysplasia in premature infants; plasmid for coding sequence |
| 03/06/2008 | US20080058276 Cis, trans isomerization; serine, threonine profile; therapy, prevention neurodegenerative disorders |
| 03/06/2008 | US20080058267 Combinatorial therapy; genetic engineered protein; therapy for autoimmune diaeses; anticancer agents |
| 03/06/2008 | US20080058263 Polypeptides that binds to cellular receptors; animal growth regukators |
| 03/06/2008 | US20080058262 rPA optimization |
| 03/06/2008 | US20080058261 Protease susceptibility II |
| 03/06/2008 | US20080058260 Reversible inhibition of pyramidal gap junction activity |
| 03/06/2008 | US20080058258 Growth Factor |
| 03/06/2008 | US20080058256 Metalloproteinase polypeptide; in vivo lysis of blood clots; genetic engineering; gene expression |
| 03/06/2008 | US20080058248 Toxin Complex Proteins and Genes from Xenorhabdus bovienii |
| 03/06/2008 | US20080058247 Polynucleotides and Polypeptides Encoding Receptors |
| 03/06/2008 | US20080058221 Methods for culture and production of single cell populations of human embryonic stem cells |
| 03/06/2008 | US20080058211 Method and Composition for the Modulation of Toxin Resistance in Plant Cells |
| 03/06/2008 | US20080057585 Phospolipid:diacylglycerol acyltransferases |
| 03/06/2008 | US20080057584 Using vector transformation to express glucose transport protein (GLUT-1) in mammalian cells; prevention and treatment of apoptosis, necrosis and proliferation inhibition |
| 03/06/2008 | US20080057583 Reverse Progeny Mapping |
| 03/06/2008 | US20080057582 Using vector comprising dihydroorotase, translation iniation factor-1a and sugar beet kinase as tool for generating drought, cold and frost resistant crop plants |
| 03/06/2008 | US20080057581 Ires Functioning In Plant |
| 03/06/2008 | US20080057580 Method of differentiation induction to osteoblasts |
| 03/06/2008 | US20080057579 Methods and products for manipulating hematopoietic stem cells |
| 03/06/2008 | US20080057578 Process and substrate for culturing cartilage cell, material for reproducing biological tissue containing cartilage cell, and cartilage cell |
| 03/06/2008 | US20080057577 Alkane Oxidation By Modified Hydroxylases |
| 03/06/2008 | US20080057576 Reactor and Method for Solid State Fermentation |
| 03/06/2008 | US20080057575 Optimizing Expression of Active Botulinum Toxin Type A |
| 03/06/2008 | US20080057566 Bacterial host cell for the direct expression of peptides |
| 03/06/2008 | US20080057565 Method for overexpression of zwitterionic polysaccharides |
| 03/06/2008 | US20080057564 Nucleotide sequences coding mitotic regulatory proteins for use identifying modulators of plant development |
| 03/06/2008 | US20080057556 Using electromagnet insult to stimulate insulin production |
| 03/06/2008 | US20080057546 Generating preferentisl nuleotide seuence using adapter molecules to mediate binding between first and second molecules; gene libraries; genomic analysis |
| 03/06/2008 | US20080057540 Novel DKR polypeptides |
| 03/06/2008 | US20080057537 Nucleic acid encoding polypeptide involved in cellular entrance of the PRRS virus |
| 03/06/2008 | US20080057529 Method for Identifying Histone Deacetylase Inhibitors |
| 03/06/2008 | US20080057519 Monoclonal antibody specific for b-cell chronic lymphocytic leukemia cell surface protein; diagnosing cell proliferative disorders of blood |
| 03/06/2008 | US20080057515 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 03/06/2008 | US20080057510 Human Vascular IBP-Like Growth Factor |
| 03/06/2008 | US20080057492 Interacting site for gp41 on gp120 of hiv-1 |
| 03/06/2008 | US20080057487 Preparing reproductive cells for transplanrtation via order exposure to nutrient broths comprising cryopreservatives, hormones, glucose, ionic constituents and amino acids; human artificial insemination |
| 03/06/2008 | US20080057095 Bone semi-permeable device |
| 03/06/2008 | US20080057071 Use Of Hedgehog Pathway Inhibitors In Small-Cell Lung Cancer |
| 03/06/2008 | US20080057070 Antagonist Anti-Cd40 Monoclonal Antibodies and Methods for Their Use |
| 03/06/2008 | US20080057069 Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue |
| 03/06/2008 | US20080057066 Methods and compositions for targeting relt |
| 03/06/2008 | US20080057065 Phep, an Amino Acid Permease of Staphylococcus Aureus |
| 03/06/2008 | US20080057064 Erbb3 Based Methods and Compositions for Treating Neoplasms |
| 03/06/2008 | US20080057063 human monoclonal antibodies; diagnostics and treatment of diseases associated with the activity and/or overproduction of alpha V beta 6; cancer |
| 03/06/2008 | US20080057058 Uses of il-23 agonists and antagonists; related reagents |
| 03/06/2008 | US20080057057 Anti-Lipid Rafts Antibodies |
| 03/06/2008 | US20080057056 Fc Variants with Increased Affinity for FcyRIIC |
| 03/06/2008 | US20080057054 Controlling activity of telencephalin |
| 03/06/2008 | US20080057043 human and mouse monocyte cells expressing angiopoietin receptors and CD14/antigen markers, used for regulating neovascularization |
| 03/06/2008 | US20080057042 Method of providing readily available cellular material derived from cord blood, and a composition thereof |
| 03/06/2008 | US20080057041 Derivation of embryonic stem cells and embryo-derived cells |
| 03/06/2008 | US20080057040 Cell Preservation Method |
| 03/06/2008 | US20080057039 analyzing maternal mitochondrial status, to detect genetic disorders such as Down Syndrome |
| 03/06/2008 | US20080057033 Neural Stem Cells and Methods of Generating and Utilizing Same |
| 03/06/2008 | US20080057028 Vegf-C or Vegf-D Materials and Methods for Stimulation of Neural Stem cells |
| 03/06/2008 | US20080056997 preferential binding members against extracellular matrix proteins, especially scFv antibody molecules against peptide domains of the glycoprostien, conjugated with labels, cytotoxic molecules or cytokines, for use in diagnosis and treatment of cancer |
| 03/06/2008 | US20080056990 Anilinoquinazolinyl amide derivatives; radiolabels as bioprobes for Positron Emission Tomography and Single Photon Emission Computed Tomography, and as radiopharmaceuticals for radiotherapy; improved solubility, bioavailability, biostability |
| 03/06/2008 | CA2697960A1 Sperm cell separation methods and compositions containing aptamers or nucleic acid sequences for use therein |
| 03/06/2008 | CA2662292A1 Isolation of cells |
| 03/06/2008 | CA2662218A1 Retinoid compounds and their use |
| 03/06/2008 | CA2662111A1 Repair of cartilage tissue using a matrix gel incorporating chondrocytes at a cell density less than that in the native cartilage tissue |
| 03/06/2008 | CA2661482A1 Separation of platelets from fluid suspensions |
| 03/06/2008 | CA2661232A1 Transcription factors for differentiation of adult human olfactory progenitor cells |
| 03/06/2008 | CA2660175A1 Variable region sequences of il-31 monoclonal antibodies and methods of use |
| 03/05/2008 | EP1895010A2 Equine infectious anaemia virus (eiav) based vectors |
| 03/05/2008 | EP1895006A1 Interleukin-17 related mammalian cytokines. Polynucleotides encoding them. Uses |
| 03/05/2008 | EP1895005A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 03/05/2008 | EP1895004A1 Human hippocalcin gene variant associated with cancers |
| 03/05/2008 | EP1895002A1 Novel trypsin family serine proteases |